medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2020, Number 3

<< Back Next >>

An Med Asoc Med Hosp ABC 2020; 65 (3)

Comorbidities in patients with cerebral palsy. Longitudinal cohort study

González-Astiazarán A, Collado-Corona MÁ, Terrazo-Lluch J, Shkurovich-Bialik P, Ramírez-Navarrete E, Arch-Tirado E, De Font-Réaulx E

Language: Spanish
References: 19
Page: 176-181
PDF size: 217.61 Kb.


ABSTRACT

Introduction: Cerebral Palsy is a chronic neurologic malady with different degrees of symptomatology, repercussion, and therapeutic schemes. The global prevalence of Cerebral Palsy is 1.2-3.6/1,000 live newborns, this figure has been stable in the last three decades in different countries, with few differences related to socioeconomic variables. Prematurity and low birth weight remain as the most important ones. The type of comorbidity is heterogeneous, frequently has the same or more importance for the medical management. Objective: To define the characteristics of the comorbidity in a population with cerebral palsy in regular clinical follow up. Material and methods: Is a longitudinal cohort study, in which we established diagnosis and classification of the primary condition and the presence of neuropsychiatric comorbidity we included patients on regular follow up from January 2013 to December 2019. Neuro psychiatric comorbidity was defined as the coexistence of abnormal conditions either primary neurologic or psychiatric conditions. Results: This series has 287 patients with Cerebral Palsy, on regular follow up from January 2013 to December 2019. The sex distribution has subtle predominance for male patients. Age distribution from one month to 57 years. The median age is nine years eight months. Hypoxic encephalopathy was the etiology in 212 cases (73.86%). Seventy patients have no comorbidity (24.39%), 84 patients (29.26%) have a single comorbidity, and multiple (two or more conditions in the same patient), was present in 113 cases (46.33%). Conclusion: Neuropsychiatric comorbidities represent medical problems that mean equal or greater impact on the quality of life of patients with infantile cerebral palsy.


REFERENCES

  1. Bax M. Terminology and classification of cerebral palsy. Dev Med Child Neurol. 1964; 6: 295-297.

  2. National Guideline Alliance (UK). Cerebral palsy in under 25s: assessment and management. London: National Institute for Health and Care Excellence (UK); (NICE Guideline, No 62), 2017.

  3. Rosenbaum P, Paneth N, Leviton A et al. A report: the definition and classification of cerebral palsy. Dev Med Child Neurol. 2007; 49 (Suppl. 109): 8-14.

  4. Shevell M, Dagenays L, Hall N. Comorbidities in cerebral palsy and their relationship to neurologic subtype and GMFCS level. Neurology. 2009; 72: 2090-2096.

  5. Hollung SJ, Vik T, Wiik R, Bakken IJ, Anderson GL. Completeness and correctness of cerebral palsy diagnosis in two health registers: implications for estimating prevalence. Dev Med Child Neurol. 2017; 59: 402-406.

  6. Galea C, Mcintyre S, Smithers-Sheedy H et al. Cerebral Palsy trends in Australia (1995-2009): a population-based observational study. Dev Med Child Neurol. 2019; 61: 186-193.

  7. Novak I, Hines M, Goldsmith S, Barcley R. Clinical prognostic messages from a systematic review on cerebral palsy. Pediatrics. 2012; 130: e1285-312.

  8. Brown JK, Eunson P, Bax M. Heterogeneity in cerebral pansy: variations in neurology, comorbidity and associated conditions. In: Bax M, Gillberg C, editors. Comorbidities in developmental disorders. London: Mac Keith Press, 2011, pp. 20-39.

  9. Surveillance of Cerebral Palsy in Europe. Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol. 2002; 44 (9): 633-640.

  10. Rosenbaum PL, Palisano RJ, Bartlett DJ, Galuppi BE, Russell DJ. Development of the gross motor function classification system for cerebral palsy. Dev Med Child Neurol. 2008; 50 (4): 249-253.

  11. Delacy MJ, Reid SM; Australian Cerebral Palsy Register Group. Profile of associated impairments at age 5 years in Australia by cerebral palsy subtype and Gross Motor Function Classification System level for birth years 1996 to 2005. Dev Med Child Neurol. 2016; 58 (Suppl 2): 50-56.

  12. Hafström M, Källén K, Serenius F et al. Cerebral palsy in extremely preterm infants. Pediatrics. 2018; 141 (1): e20171433.

  13. Datos de INEGI. [Fecha de consulta 12 julio de 2020] Disponible en: https://inegi.org.mx.

  14. Caraveo J, Medina-Mora ME, Rascón ML, Villatoro J, López EK, Juárez F et al. Características psicopatológicas de la población adulta urbana en México. Resultados de una Encuesta Nacional en Hogares. Instituto Mexicano de Psiquiatría, 1994, pp. 22-37.

  15. Caraveo et al. Diagnóstico epidemiológico. [12 julio de 2020] Disponible en: http://www.salud.gob.mx/unidades/cdi/documentos/pasm_cap3.pdf.

  16. Rodríguez J, Kohn R, Aguilar-Gaxiola S et al. Epidemiología de los trastornos mentales en América Latina y el Caribe. Washington DC: Organización Panamericana de la Salud, 2009, pp. 96-106.

  17. Guía Clínica. Trastorno por Déficit de Atención e Hiperactividad. Hospital Psiquiátrico Infantil “Dr. Juan N. Navarro” 2009 ISBN 978-607-955.

  18. Hollung SJ, Bakken IJ, Vik T et al. Comorbidities in cerebral palsy: a patient registry study. Dev Med Child Neurol. 2020; 62: 97-103.

  19. Pruitt DW, Tsai T. Common medical comorbidities associated with cerebral palsy. Phys Med Rehabil Clin N Am. 2009; 20: 453-467.




2020     |     www.medigraphic.com